MARKET

CPRX

CPRX

Catalyst Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.160
-0.120
-2.80%
After Hours: 4.160 0 0.00% 16:30 01/17 EST
OPEN
4.310
PREV CLOSE
4.280
HIGH
4.310
LOW
4.130
VOLUME
1.43M
TURNOVER
--
52 WEEK HIGH
7.67
52 WEEK LOW
2.170
MARKET CAP
428.65M
P/E (TTM)
49.88
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CPRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CPRX News

  • Implied Volatility Surging for Catalyst (CPRX) Stock Options
  • Zacks.3d ago
  • Catalyst Pharmaceuticals Option Alert: Jun 19 $2.5 Calls Sweep (24) near the Ask: 721 @ $2.101 vs 2259 OI; Ref=$4.19
  • Benzinga.4d ago
  • Catalyst Gives Preliminary Firdapse Estimates & Other Updates
  • Zacks.01/07 14:17
  • Catalyst Pharma up 5% on bullish Firdapse forecast
  • seekingalpha.01/06 21:03

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About CPRX

Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., is a development-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for people with rare debilitating diseases. The Company has three drugs in development: Firdapse, CPP-109 and CPP-115. The Company's Firdapse is indicated for the treatments of lambert-eaton myasthenic syndrome (LEMS) and congenital myasthenic syndromes (CMS). Firdapse consists of the phosphate salt of amifampridine. The Company has completed the Phase III trial of Firdapse. The Company's CPP-109 (vigabatrin) is a gamma-aminobutyric acid (GABA) aminotransferase inhibitor. CPP-109 is indicated for the treatment of Tourette's Disorder. The Company's CPP-115 is a GABA aminotransferase inhibitor. CPP-115 is indicated for the treatment of selected neurological indications, such as complex partial seizures and Tourette's Disorder, and epilepsy.
More

Webull offers Catalyst Pharmaceuticals Inc (CPRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.